[ad_1] Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the nervous system, has published an article on the transplantation of NSI-532.IGF1 in the scientific journal …
Read More »The neural stem announces the results of neural stem cell transplant studies on a mouse model of Alzheimer's disease
